An International Publisher for Academic and Scientific Journals
Author Login
Scholars Academic Journal of Pharmacy | Volume-6 | Issue-09
Formulation and Characterization of Tramadol Emulgel
Beedha Saraswathi, SK. Shabana, D. Ramya Sri, D. Anantha lakshmi, M. Shivaji, T. Satyanarayana
Published: Sept. 30, 2017 |
273
117
DOI: 10.21276/sajp.2017.6.9.3
Pages: 383-390
Downloads
Abstract
Topical drug delivery system (TDDS) facilitates the passage of therapeutic
quantities of drug substance through the skin and into the general circulation for their
systemic effects. Although having plenty of advantages over other routes of
administration topical drug delivery system is having certain limitations including
hydrophilic drugs cannot easily penetrate across skin, to overcome this problem drug
made into sufficient lipophilic or lipophilic drugs are sued along with certain penetration
enhancers which help to achieve desired results. Tramadol is a narcotic analgesic
proposed for moderate to severe pain. It may be habituating. Tramadol and its metabolites
are excreted primarily in the urine with observed plasma half-lives of 6.3 and 7.4 hours
for tramadol and M1, respectively. Approximately 30% of the dose is excreted in the
urine as unchanged drug, whereas 60% of the dose is excreted as metabolites. On this
contest, emulgel was formulated using carbopol 934 and HPMC K15M, liquid paraffin as
oil phase, emulsifying agents like tween 20 and span 20 and propylene glycol as
permeation enhancers.